An 8‐week, open‐label, dose‐finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations — latest news, discussion & facts — IJR
An 8‐week, open‐label, dose‐finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
scholarly article
An 8‐week, open‐label, dose‐finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations
scientific article published on September 12, 2017
Latest An 8‐week, open‐label, dose‐finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations news and discussion
Sort by
Content type
Nothing published yet
The conversation starts anyway — post the first discussion above.
